Medicinal preparations containing antigens or antibodies

Industry

  • CPC
  • A61K39/00
This industry / category may be too specific. Please go to a parent level for more data

Sub Industries

A61K39/0001Archaeal antigens A61K39/0002Fungal antigens A61K39/0003Invertebrate antigens A61K39/0005Vertebrate antigens A61K39/0006Contraceptive vaccins; Vaccines against sex hormones A61K39/0007Nervous system antigens; Prions A61K39/0008Antigens related to auto-immune diseases; Preparations to induce self-tolerance A61K39/001Preparations to induce tolerance to non-self A61K39/0011Cancer antigens A61K39/0012Lipids; Lipoproteins A61K39/0013Therapeutic immunisation against small organic molecules A61K39/0015Combination vaccines based on measles-mumps-rubella A61K39/0016Combination vaccines based on diphtheria-tetanus-pertussis A61K39/0017Combination vaccines based on whole cell diphtheria-tetanus-pertussis A61K39/0018Combination vaccines based on acellular diphtheria-tetanus-pertussis A61K39/002Protozoa antigens A61K39/005Trypanosoma antigens A61K39/008Leishmania antigens A61K39/012Coccidia antigens A61K39/015Hemosporidia antigens A61K39/018Babesia antigens A61K39/02Bacterial antigens A61K39/0208Specific bacteria not otherwise provided for A61K39/0216Bacteriodetes A61K39/0225Spirochetes A61K39/0233Rickettsiales A61K39/0241Mollicutes A61K39/025Enterobacteriales A61K39/0258Escherichia A61K39/0266Klebsiella A61K39/0275Salmonella A61K39/0283Shigella A61K39/0291Yersinia A61K39/04Mycobacterium A61K39/05Actinobacteria A61K39/07Bacillus A61K39/08Clostridium A61K39/085Staphylococcus A61K39/09Lactobacillales A61K39/092Streptococcus A61K39/095Neisseria A61K39/098Brucella A61K39/099Bordetella A61K39/102Pasteurellales A61K39/104Pseudomonadales A61K39/1045Moraxella A61K39/105Delta proteobacteriales A61K39/107Vibrio A61K39/114Fusobacterium A61K39/116Polyvalent bacterial antigens A61K39/118Chlamydiaceae A61K39/12Viral antigens A61K39/125Picornaviridae A61K39/13Poliovirus A61K39/135Foot- and mouth-disease virus A61K39/145Orthomyxoviridae A61K39/15Reoviridae A61K39/155Paramyxoviridae A61K39/165Mumps or measles virus A61K39/17Newcastle disease virus A61K39/175Canine distemper virus A61K39/187Hog cholera virus A61K39/193Equine encephalomyelitis virus A61K39/20Rubella virus A61K39/205Rhabdoviridae A61K39/21Retroviridae A61K39/215Coronaviradae A61K39/225Porcine transmissible gastroenteritis virus A61K39/23Parvoviridae A61K39/235Adenoviridae A61K39/245Herpetoviridae A61K39/25Varicella-zoster virus A61K39/255Marek's disease virus A61K39/265Infectious rhinotracheitis virus A61K39/27Equine rhinopneumonitis virus A61K39/275Poxviridae A61K39/285Vaccinia virus or variola virus A61K39/29Hepatitis virus A61K39/292Serum hepatitis virus, hepatitis B virus A61K39/295Polyvalent viral antigens Mixtures of viral and bacterial antigens A61K39/35Allergens A61K39/36from pollen A61K39/38Antigens from snakes A61K39/385Haptens or antigens, bound to carriers A61K39/39characterised by the immunostimulating additives A61K39/395Antibodies Immunoglobulins Immune serum A61K39/39508from milk A61K39/39516from serum, plasma A61K39/39525Purification A61K39/39533against materials from animals A61K39/39541against normal tissues, cells A61K39/3955against proteinaceous materials A61K39/39558against tumor tissues, cells, antigens A61K39/39566against immunoglobulins A61K39/39575against materials from other living beings excluding bacteria and viruses A61K39/39583against materials not provided for elsewhere A61K39/39591Stabilisation, fragmentation A61K39/40bacterial A61K39/42viral A61K39/44Antibodies bound to carriers
processing...
processing...

Patent Grants - Issue Datelast 12 months

processing...

Patent Applications - Publication Datelast 12 months

processing...